Description
About Neomustin 100 mg Injection
Neomustin 100 mg Injection contains bendamustine, supplied as a vial for intravenous infusion after reconstitution and dilution. It is prepared and given by trained healthcare staff.
How it works
Bendamustine is a cytotoxic medicine with alkylating activity. It binds to the DNA inside dividing cells and causes damage the cell cannot repair, so the cell stops multiplying and dies. Treatment is given in supervised cycles with regular blood tests.
What it is used for
Bendamustine is used in the treatment of chronic lymphocytic leukaemia and of indolent non-Hodgkin lymphomas, including after other treatments have stopped working, and in multiple myeloma in some regimens.
Important safety information
Bendamustine lowers white cells, red cells and platelets, raising the risk of infection, anaemia and bleeding; blood counts are checked before and between cycles. Serious skin reactions, infusion reactions and tumour lysis syndrome can occur. It can harm an unborn baby. Report fever, sore throat, unusual bruising or bleeding, or any rash straight away, and tell your doctor about all other medicines and any kidney or liver problems.
This is a prescription-only medicine. It should be used only under the supervision of a qualified healthcare professional, who will decide whether it is suitable for you and at what dose.
Reviews
There are no reviews yet.